Next-generation sequencing reveals the biological significance of the N 2,3-ethenoguanine lesion in vivo

Abstract

Abstract Etheno DNA adducts are a prevalent type of DNA damage caused by vinyl chloride (VC) exposure and oxidative stress. Etheno adducts are mutagenic and may contribute to the initiation of several pathologies; thus, elucidating the pathways by which they induce cellular transformation is critical. Although N  2,3-ethenoguanine (N  2,3-εG) is the most abundant etheno adduct, its biological consequences have not been well characterized in cells due to its labile glycosidic bond. Here, a stabilized 2′-fluoro-2′-deoxyribose analog of N  2,3-εG was used to quantify directly its genotoxicity and mutagenicity. A multiplex method involving next-generation sequencing enabled a large-scale in vivo analysis, in which both N  2,3-εG and its isomer 1,N  2-ethenoguanine (1,N  2-εG) were evaluated in various repair and replication backgrounds. We found that N  2,3-εG potently induces G to A transitions, the same mutation previously observed in VC-associated tumors. By contrast, 1,N  2-εG induces various substitutions and frameshifts. We also found that N  2,3-εG is the only etheno lesion that cannot be repaired by AlkB, which partially explains its persistence. Both εG lesions are strong replication blocks and DinB, a translesion polymerase, facilitates the mutagenic bypass of both lesions. Collectively, our results indicate that N  2,3-εG is a biologically important lesion and may have a functional role in VC-induced or inflammation-driven carcinogenesis.